A Study of the Safety and PK of PCS6422 (Eniluracil) with Capecitabine in Patients with Advanced, Refractory GI Tract Tumors
Clinical trial NCT04861987 · COMPLETED
Trial details
- NCT number
- NCT04861987
- Sponsor
- Processa Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-18
- Primary completion
- 2024-06-12
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.